Frishman Gary N, Spencer Patricia K, Weitzen Sherry, Plosker Shayne, Shafi Farah
Department of Obstetrics and Gynecology, Women & Infants' Hospital, Brown Medical School, Providence, RI 02905, USA.
Obstet Gynecol. 2004 Jun;103(6):1261-6. doi: 10.1097/01.AOG.0000127370.66704.f5.
A hysterosalpingogram is an integral part of the evaluation of infertility but is often painful. Intrauterine anesthesia may help to alleviate the discomfort associated with this procedure.
We conducted a randomized, double-blinded, placebo-controlled trial of intrauterine lidocaine in women undergoing hysterosalpingography (HSG). All women were instructed to take a nonsteroidal analgesic before the hysterosalpingogram. Patients received 3 mL of buffered 2% lidocaine solution or 0.9% normal saline instilled into the uterus before HSG. The primary outcome was the degree of pain experienced documented via 10-cm visual analogue pain scales. Systematic assessments of discomfort were also collected by the attending physician, radiology technician, and radiology physician.
Sixty-four patients were randomly assigned to placebo and 63 women were randomly assigned to the lidocaine group. There were no differences in mean age, race, parity, or history of dysmenorrhea or chronic pelvic pain. There were no differences in the pain scores at baseline, during, or after the study procedure between the 2 groups. Peak pain scale scores associated with the procedure were 5.3 +/- 0.4 in both the placebo and study groups. In addition, assessments of patient discomfort revealed no significant differences between the 2 groups.
We found no difference in pain between the intrauterine-lidocaine and placebo groups. Intrauterine lidocaine does not appear to be effective in decreasing pain in women undergoing HSG.
I
子宫输卵管造影是不孕症评估的重要组成部分,但该检查常伴有疼痛。子宫内麻醉可能有助于减轻与该检查相关的不适。
我们对接受子宫输卵管造影(HSG)的女性进行了一项关于子宫内注射利多卡因的随机、双盲、安慰剂对照试验。所有女性在子宫输卵管造影前均被要求服用一种非甾体类镇痛药。患者在HSG前接受3毫升缓冲的2%利多卡因溶液或0.9%生理盐水注入子宫。主要结局是通过10厘米视觉模拟疼痛量表记录的疼痛程度。主治医生、放射技师和放射科医生也对不适情况进行了系统评估。
64例患者被随机分配至安慰剂组,63例女性被随机分配至利多卡因组。两组在平均年龄、种族、产次、痛经或慢性盆腔疼痛病史方面无差异。两组在研究操作基线、操作期间或操作后的疼痛评分无差异。安慰剂组和研究组与该操作相关的疼痛量表峰值评分均为5.3±0.4。此外,对患者不适情况的评估显示两组之间无显著差异。
我们发现子宫内注射利多卡因组和安慰剂组在疼痛方面无差异。子宫内注射利多卡因似乎对减轻接受HSG检查女性的疼痛无效。
I